US Patent Issued to Vanda Pharmaceuticals on Jan. 20 for "Pharmaceutical combination comprising ponesimod" (Swiss Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,772, issued on Jan. 20, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Pharmaceutical combination comprising ponesimod" was invented by Martine Clozel (Allschwil, Switzerland) and Laetitia Pouzol (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide."

The patent was filed on June 27, 2023, under Application No. 18/341,853.

*For further information, including images, charts and tables, please visit:...